AGRX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 14:00):

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States...

Stats
Today's Volume	85 666.00
Average Volume	731 062
Market Cap	2.74M
EPS	$-1.510 ( 2024-03-28 )
Next earnings date	( $-0.510 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0600
ATR14	$0.00700 (1.75%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-03	Coiante Scott M	Buy	20 000	Common Stock
2023-08-16	Coiante Scott M	Sell	0	Common Stock
2023-06-28	Welsh Amy	Buy	13 500	Common Stock
2023-06-28	Welsh Amy	Buy	4 500	Employee Stock Option (Right to Buy)
2023-06-28	Korner Paul	Buy	13 500	Common Stock

INSIDER POWER
99.59
Last 98 transactions
Buy: 13 666 273 \| Sell: 187 248

Agile Therapeutics Inc Correlation

10 Most Positive Correlations
PXS	0.967
IONM	0.964
IVAC	0.959
KPTI	0.958
KPRX	0.953
ENTA	0.952
AACG	0.952
NSTG	0.948
RVSN	0.947
PRQR	0.947

10 Most Negative Correlations
VRSK	-0.961
EVLV	-0.953
BTWN	-0.952
QTRX	-0.949
PKOH	-0.946
IMTX	-0.944
PRSR	-0.938
SPNS	-0.936
MDRRP	-0.935
AMZN	-0.933

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Agile Therapeutics Inc Financials

Annual	2023
Revenue:	$19.59M
Gross Profit:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2023
Revenue:	$19.59M
Gross Profit:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2022
Revenue:	$10.88M
Gross Profit:	$4.05M (37.19 %)
EPS:	$-58.79

FY	2021
Revenue:	$4.10M
Gross Profit:	$-6.62M (-161.35 %)
EPS:	$-0.884

Financial Reports:

No articles found.

Agile Therapeutics Inc

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.